Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Document Type
- Journal article (9)
- Doctoral Thesis (1)
Keywords
- radioligand therapy (2)
- 3D printing (1)
- 7 T (1)
- Alternative Medizin (1)
- Alternativmedizin (1)
- B (1)
- CT-angiography (1)
- Computed axial tomography (1)
- Diagnostic medicine (1)
- FOLFIRI (1)
- FOLFOX (1)
- Fats (1)
- Inflammatory diseases (1)
- Komplimentärmedizin (1)
- Mastoid process (1)
- Onkologie (1)
- PET (1)
- PSA (1)
- PSMA (1)
- Prädiktoren (1)
- Radiation exposure (1)
- Soft tissues (1)
- X-ray radiography (1)
- [\(^{68}\)Ga]Ga-FAPI (1)
- adenocarcinoma of the ampulla of Vater (1)
- cardiac MRI (1)
- cardiovascular MRI (1)
- cone-beamcomputed tomography (1)
- coronary arteries (1)
- dual-energy (1)
- embolism/thrombosis (1)
- extremities (1)
- fibroblast activation protein (1)
- flare phenomenon (1)
- fractures, bone (1)
- gemcitabine (1)
- heart (1)
- image processing (1)
- in vivo imaging (1)
- intestinal-type adenocarcinoma (1)
- large animal models (1)
- late response (1)
- magnetic resonance imaging (1)
- nanoparticle albumin-bound paclitaxel (1)
- organoid (1)
- pancreatobiliary type (1)
- pig (1)
- prostate cancer (1)
- pulmonary arteries (1)
- radiography (1)
- research infrastructure (1)
- shimming (1)
- signal to noise ratio (1)
- stenosis (1)
- theranostics (1)
- thorax (1)
- translational research (1)
- ultrahigh field (1)
- ultrahigh-field MRI (1)
- vascular (1)
Institute
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (6)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (3)
- Klinik und Poliklinik für Nuklearmedizin (2)
- Medizinische Klinik und Poliklinik I (2)
- Medizinische Klinik und Poliklinik II (2)
- Institut für Anatomie und Zellbiologie (1)
- Institut für Experimentelle Biomedizin (1)
- Institut für Hygiene und Mikrobiologie (1)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (1)
- Medizinische Fakultät (1)
(1) Background: We aimed to quantitatively investigate [\(^{68}\)Ga]Ga-FAPI-04 uptake in normal organs and to assess a relationship with the extent of FAPI-avid tumor burden. (2) Methods: In this single-center retrospective analysis, thirty-four patients with solid cancers underwent a total of 40 [\(^{68}\)Ga]Ga-FAPI-04 PET/CT scans. Mean standardized uptake values (SUV\(_{mean}\)) for normal organs were established by placing volumes of interest (VOIs) in the heart, liver, spleen, pancreas, kidneys, and bone marrow. Total tumor burden was determined by manual segmentation of tumor lesions with increased uptake. For tumor burden, quantitative assessment included maximum SUV (SUV\(_{max}\)), tumor volume (TV), and fractional tumor activity (FTA = TV × SUV\(_{mean}\)). Associations between uptake in normal organs and tumor burden were investigated by applying Spearman's rank correlation coefficient. (3) Results: Median SUV\(_{mean}\) values were 2.15 in the pancreas (range, 1.05–9.91), 1.42 in the right (range, 0.57–3.06) and 1.41 in the left kidney (range, 0.73–2.97), 1.2 in the heart (range, 0.46–2.59), 0.86 in the spleen (range, 0.55–1.58), 0.65 in the liver (range, 0.31–2.11), and 0.57 in the bone marrow (range, 0.26–0.94). We observed a trend towards significance for uptake in the myocardium and tumor-derived SUV\(_{max}\) (ρ = 0.29, p = 0.07) and TV (ρ = −0.30, p = 0.06). No significant correlation was achieved for any of the other organs: SUV\(_{max}\) (ρ ≤ 0.1, p ≥ 0.42), TV (ρ ≤ 0.11, p ≥ 0.43), and FTA (ρ ≤ 0.14, p ≥ 0.38). In a sub-analysis exclusively investigating patients with high tumor burden, significant correlations of myocardial uptake with tumor SUV\(_{max}\) (ρ = 0.44; p = 0.03) and tumor-derived FTA with liver uptake (ρ = 0.47; p = 0.02) were recorded. (4) Conclusions: In this proof-of-concept study, quantification of [\(^{68}\)Ga]Ga-FAPI-04 PET showed no significant correlation between normal organs and tumor burden, except for a trend in the myocardium. Those preliminary findings may trigger future studies to determine possible implications for treatment with radioactive FAP-targeted drugs, as higher tumor load or uptake may not lead to decreased doses in the majority of normal organs.